Global Equine Pharmaceuticals and Supplements Market Growth 2020-2025
According to this study, over the next five years the Equine Pharmaceuticals and Supplements market will register a 4.7%% CAGR in terms of revenue, the global market size will reach $ 1314.6 million by 2025, from $ 1095.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Equine Pharmaceuticals and Supplements business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Pharmaceuticals and Supplements market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Equine Pharmaceuticals and Supplements, covering the supply chain analysis, impact assessment to the Equine Pharmaceuticals and Supplements market size growth rate in several scenarios, and the measures to be undertaken by Equine Pharmaceuticals and Supplements companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Pharmaceuticals
Supplements
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Thoroughbred Horse
Other Types of Horses
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Boehringer Ingelheim
Kyoritsu Seiyaku
Merck Animal Health
Bayer Animal Health
Elanco Animal Health
Zoetis
Virbac
Dechra Veterinary Products
Norbrook Equine
CEVA
Vetoquinol
Ouro Fino Saude
Audevard
Protexin Healthcare
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Equine Pharmaceuticals and Supplements consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Equine Pharmaceuticals and Supplements market by identifying its various subsegments.
Focuses on the key global Equine Pharmaceuticals and Supplements manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Equine Pharmaceuticals and Supplements with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Equine Pharmaceuticals and Supplements submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Consumption 2015-2025
2.1.2 Equine Pharmaceuticals and Supplements Consumption CAGR by Region
2.2 Equine Pharmaceuticals and Supplements Segment by Type
2.2.1 Pharmaceuticals
2.2.2 Supplements
2.3 Equine Pharmaceuticals and Supplements Consumption by Type
2.3.1 Global Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
2.3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2015-2020)
2.3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Type (2015-2020)
2.4 Equine Pharmaceuticals and Supplements Segment by Application
2.4.1 Thoroughbred Horse
2.4.2 Other Types of Horses
2.5 Equine Pharmaceuticals and Supplements Consumption by Application
2.5.1 Global Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
2.5.2 Global Equine Pharmaceuticals and Supplements Value and Market Share by Type (2015-2020)
2.5.3 Global Equine Pharmaceuticals and Supplements Sale Price by Type (2015-2020)
3 Global Equine Pharmaceuticals and Supplements by Company
3.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Company
3.1.1 Global Equine Pharmaceuticals and Supplements Sales by Company (2018-2020)
3.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2018-2020)
3.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company
3.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Company (2018-2020)
3.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2018-2020)
3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Company
3.4 Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Equine Pharmaceuticals and Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Equine Pharmaceuticals and Supplements by Regions
4.1 Equine Pharmaceuticals and Supplements by Regions
4.2 Americas Equine Pharmaceuticals and Supplements Consumption Growth
4.3 APAC Equine Pharmaceuticals and Supplements Consumption Growth
4.4 Europe Equine Pharmaceuticals and Supplements Consumption Growth
4.5 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Growth
5 Americas
5.1 Americas Equine Pharmaceuticals and Supplements Consumption by Countries
5.1.1 Americas Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020)
5.1.2 Americas Equine Pharmaceuticals and Supplements Value by Countries (2015-2020)
5.2 Americas Equine Pharmaceuticals and Supplements Consumption by Type
5.3 Americas Equine Pharmaceuticals and Supplements Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Equine Pharmaceuticals and Supplements Consumption by Regions
6.1.1 APAC Equine Pharmaceuticals and Supplements Consumption by Regions (2015-2020)
6.1.2 APAC Equine Pharmaceuticals and Supplements Value by Regions (2015-2020)
6.2 APAC Equine Pharmaceuticals and Supplements Consumption by Type
6.3 APAC Equine Pharmaceuticals and Supplements Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Equine Pharmaceuticals and Supplements by Countries
7.1.1 Europe Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020)
7.1.2 Europe Equine Pharmaceuticals and Supplements Value by Countries (2015-2020)
7.2 Europe Equine Pharmaceuticals and Supplements Consumption by Type
7.3 Europe Equine Pharmaceuticals and Supplements Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Equine Pharmaceuticals and Supplements by Countries
8.1.1 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Equine Pharmaceuticals and Supplements Value by Countries (2015-2020)
8.2 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Type
8.3 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Equine Pharmaceuticals and Supplements Distributors
10.3 Equine Pharmaceuticals and Supplements Customer
11 Global Equine Pharmaceuticals and Supplements Market Forecast
11.1 Global Equine Pharmaceuticals and Supplements Consumption Forecast (2021-2025)
11.2 Global Equine Pharmaceuticals and Supplements Forecast by Regions
11.2.1 Global Equine Pharmaceuticals and Supplements Forecast by Regions (2021-2025)
11.2.2 Global Equine Pharmaceuticals and Supplements Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Equine Pharmaceuticals and Supplements Forecast by Type
11.8 Global Equine Pharmaceuticals and Supplements Forecast by Application
12 Key Players Analysis
12.1 Boehringer Ingelheim
12.1.1 Company Information
12.1.2 Equine Pharmaceuticals and Supplements Product Offered
12.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Boehringer Ingelheim Latest Developments
12.2 Kyoritsu Seiyaku
12.2.1 Company Information
12.2.2 Equine Pharmaceuticals and Supplements Product Offered
12.2.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Kyoritsu Seiyaku Latest Developments
12.3 Merck Animal Health
12.3.1 Company Information
12.3.2 Equine Pharmaceuticals and Supplements Product Offered
12.3.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Merck Animal Health Latest Developments
12.4 Bayer Animal Health
12.4.1 Company Information
12.4.2 Equine Pharmaceuticals and Supplements Product Offered
12.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Bayer Animal Health Latest Developments
12.5 Elanco Animal Health
12.5.1 Company Information
12.5.2 Equine Pharmaceuticals and Supplements Product Offered
12.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Elanco Animal Health Latest Developments
12.6 Zoetis
12.6.1 Company Information
12.6.2 Equine Pharmaceuticals and Supplements Product Offered
12.6.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Zoetis Latest Developments
12.7 Virbac
12.7.1 Company Information
12.7.2 Equine Pharmaceuticals and Supplements Product Offered
12.7.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Virbac Latest Developments
12.8 Dechra Veterinary Products
12.8.1 Company Information
12.8.2 Equine Pharmaceuticals and Supplements Product Offered
12.8.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Dechra Veterinary Products Latest Developments
12.9 Norbrook Equine
12.9.1 Company Information
12.9.2 Equine Pharmaceuticals and Supplements Product Offered
12.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Norbrook Equine Latest Developments
12.10 CEVA
12.10.1 Company Information
12.10.2 Equine Pharmaceuticals and Supplements Product Offered
12.10.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 CEVA Latest Developments
12.11 Vetoquinol
12.11.1 Company Information
12.11.2 Equine Pharmaceuticals and Supplements Product Offered
12.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Vetoquinol Latest Developments
12.12 Ouro Fino Saude
12.12.1 Company Information
12.12.2 Equine Pharmaceuticals and Supplements Product Offered
12.12.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Ouro Fino Saude Latest Developments
12.13 Audevard
12.13.1 Company Information
12.13.2 Equine Pharmaceuticals and Supplements Product Offered
12.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Audevard Latest Developments
12.14 Protexin Healthcare
12.14.1 Company Information
12.14.2 Equine Pharmaceuticals and Supplements Product Offered
12.14.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Protexin Healthcare Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Equine Pharmaceuticals and Supplements Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Pharmaceuticals
Table 5. Major Players of Supplements
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
Table 8. Global Equine Pharmaceuticals and Supplements Revenue by Type (2015-2020) ($ million)
Table 9. Global Equine Pharmaceuticals and Supplements Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Equine Pharmaceuticals and Supplements Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020)
Table 13. Global Equine Pharmaceuticals and Supplements Value by Application (2015-2020)
Table 14. Global Equine Pharmaceuticals and Supplements Value Market Share by Application (2015-2020)
Table 15. Global Equine Pharmaceuticals and Supplements Sale Price by Application (2015-2020)
Table 16. Global Equine Pharmaceuticals and Supplements Sales by Company (2017-2019) (K Units)
Table 17. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2017-2019)
Table 18. Global Equine Pharmaceuticals and Supplements Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2017-2019)
Table 20. Global Equine Pharmaceuticals and Supplements Sale Price by Company (2017-2019)
Table 21. Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Equine Pharmaceuticals and Supplements Products Offered
Table 23. Equine Pharmaceuticals and Supplements Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Equine Pharmaceuticals and Supplements Consumption by Regions 2015-2020 (K Units)
Table 25. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Regions 2015-2020
Table 26. Global Equine Pharmaceuticals and Supplements Value by Regions 2015-2020 ($ Millions)
Table 27. Global Equine Pharmaceuticals and Supplements Value Market Share by Regions 2015-2020
Table 28. Americas Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Countries (2015-2020)
Table 30. Americas Equine Pharmaceuticals and Supplements Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Equine Pharmaceuticals and Supplements Value Market Share by Countries (2015-2020)
Table 32. Americas Equine Pharmaceuticals and Supplements Consumption by Type (2015-2020) (K Units)
Table 33. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
Table 34. Americas Equine Pharmaceuticals and Supplements Consumption by Application (2015-2020) (K Units)
Table 35. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020)
Table 36. APAC Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Countries (2015-2020)
Table 38. APAC Equine Pharmaceuticals and Supplements Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Equine Pharmaceuticals and Supplements Value Market Share by Regions (2015-2020)
Table 40. APAC Equine Pharmaceuticals and Supplements Consumption by Type (2015-2020) (K Units)
Table 41. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
Table 42. APAC Equine Pharmaceuticals and Supplements Consumption by Application (2015-2020) (K Units)
Table 43. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020)
Table 44. Europe Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Countries (2015-2020)
Table 46. Europe Equine Pharmaceuticals and Supplements Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Equine Pharmaceuticals and Supplements Value Market Share by Countries (2015-2020)
Table 48. Europe Equine Pharmaceuticals and Supplements Consumption by Type (2015-2020) (K Units)
Table 49. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
Table 50. Europe Equine Pharmaceuticals and Supplements Consumption by Application (2015-2020) (K Units)
Table 51. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Equine Pharmaceuticals and Supplements Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Equine Pharmaceuticals and Supplements Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020)
Table 60. Equine Pharmaceuticals and Supplements Distributors List
Table 61. Equine Pharmaceuticals and Supplements Customer List
Table 62. Global Equine Pharmaceuticals and Supplements Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Equine Pharmaceuticals and Supplements Consumption Market Forecast by Regions
Table 64. Global Equine Pharmaceuticals and Supplements Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Equine Pharmaceuticals and Supplements Value Market Share Forecast by Regions
Table 66. Global Equine Pharmaceuticals and Supplements Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Equine Pharmaceuticals and Supplements Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Equine Pharmaceuticals and Supplements Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Equine Pharmaceuticals and Supplements Value Market Share Forecast by Type (2021-2025)
Table 70. Global Equine Pharmaceuticals and Supplements Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Equine Pharmaceuticals and Supplements Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Equine Pharmaceuticals and Supplements Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Equine Pharmaceuticals and Supplements Value Market Share Forecast by Application (2021-2025)
Table 74. Boehringer Ingelheim Product Offered
Table 75. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Boehringer Ingelheim Main Business
Table 77. Boehringer Ingelheim Latest Developments
Table 78. Boehringer Ingelheim Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 79. Kyoritsu Seiyaku Product Offered
Table 80. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Kyoritsu Seiyaku Main Business
Table 82. Kyoritsu Seiyaku Latest Developments
Table 83. Kyoritsu Seiyaku Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Animal Health Product Offered
Table 85. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Merck Animal Health Main Business
Table 87. Merck Animal Health Latest Developments
Table 88. Merck Animal Health Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 89. Bayer Animal Health Product Offered
Table 90. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Bayer Animal Health Main Business
Table 92. Bayer Animal Health Latest Developments
Table 93. Bayer Animal Health Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 94. Elanco Animal Health Product Offered
Table 95. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Elanco Animal Health Main Business
Table 97. Elanco Animal Health Latest Developments
Table 98. Elanco Animal Health Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 99. Zoetis Product Offered
Table 100. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Zoetis Main Business
Table 102. Zoetis Latest Developments
Table 103. Zoetis Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 104. Virbac Product Offered
Table 105. Virbac Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 106. Virbac Main Business
Table 107. Virbac Latest Developments
Table 108. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Dechra Veterinary Products Product Offered
Table 110. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Dechra Veterinary Products Main Business
Table 112. Dechra Veterinary Products Latest Developments
Table 113. Dechra Veterinary Products Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 114. Norbrook Equine Product Offered
Table 115. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Norbrook Equine Main Business
Table 117. Norbrook Equine Latest Developments
Table 118. Norbrook Equine Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 119. CEVA Product Offered
Table 120. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. CEVA Main Business
Table 122. CEVA Latest Developments
Table 123. CEVA Basic Information, Company Total Revenue (in $ million), Equine Pharmaceuticals and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 124. Vetoquinol Product Offered
Table 125. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. Vetoquinol Main Business
Table 127. Vetoquinol Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Vetoquinol Latest Developments
Table 129. Ouro Fino Saude Product Offered
Table 130. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. Ouro Fino Saude Main Business
Table 132. Ouro Fino Saude Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Ouro Fino Saude Latest Developments
Table 134. Audevard Product Offered
Table 135. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 136. Audevard Main Business
Table 137. Audevard Latest Developments
Table 138. Audevard Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Protexin Healthcare Product Offered
Table 140. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 141. Protexin Healthcare Main Business
Table 142. Protexin Healthcare Latest Developments
Table 143. Protexin Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Equine Pharmaceuticals and Supplements
Figure 2. Equine Pharmaceuticals and Supplements Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Equine Pharmaceuticals and Supplements Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Equine Pharmaceuticals and Supplements Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Pharmaceuticals
Figure 7. Product Picture of Supplements
Figure 8. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
Figure 9. Global Equine Pharmaceuticals and Supplements Value Market Share by Type (2015-2020)
Figure 10. Equine Pharmaceuticals and Supplements Consumed in Thoroughbred Horse
Figure 11. Global Equine Pharmaceuticals and Supplements Market: Thoroughbred Horse (2015-2020) (K Units)
Figure 12. Global Equine Pharmaceuticals and Supplements Market: Thoroughbred Horse (2015-2020) ($ Millions)
Figure 13. Equine Pharmaceuticals and Supplements Consumed in Other Types of Horses
Figure 14. Global Equine Pharmaceuticals and Supplements Market: Other Types of Horses (2015-2020) (K Units)
Figure 15. Global Equine Pharmaceuticals and Supplements Market: Other Types of Horses (2015-2020) ($ Millions)
Figure 16. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Application (2015-2020)
Figure 17. Global Equine Pharmaceuticals and Supplements Value Market Share by Application (2015-2020)
Figure 18. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company in 2017
Figure 19. Global Equine Pharmaceuticals and Supplements Sales Market Share by Company in 2019
Figure 20. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company in 2017
Figure 21. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company in 2019
Figure 22. Global Equine Pharmaceuticals and Supplements Sale Price by Company in 2019
Figure 23. Global Equine Pharmaceuticals and Supplements Consumption Market Share by Regions 2015-2020
Figure 24. Global Equine Pharmaceuticals and Supplements Value Market Share by Regions 2015-2020
Figure 25. Americas Equine Pharmaceuticals and Supplements Consumption 2015-2020 (K Units)
Figure 26. Americas Equine Pharmaceuticals and Supplements Value 2015-2020 ($ Millions)
Figure 27. APAC Equine Pharmaceuticals and Supplements Consumption 2015-2020 (K Units)
Figure 28. APAC Equine Pharmaceuticals and Supplements Value 2015-2020 ($ Millions)
Figure 29. Europe Equine Pharmaceuticals and Supplements Consumption 2015-2020 (K Units)
Figure 30. Europe Equine Pharmaceuticals and Supplements Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Equine Pharmaceuticals and Supplements Value 2015-2020 ($ Millions)
Figure 33. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Countries in 2019
Figure 34. Americas Equine Pharmaceuticals and Supplements Value Market Share by Countries in 2019
Figure 35. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Type in 2019
Figure 36. Americas Equine Pharmaceuticals and Supplements Consumption Market Share by Application in 2019
Figure 37. United States Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 38. United States Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Countries in 2019
Figure 44. APAC Equine Pharmaceuticals and Supplements Value Market Share by Regions in 2019
Figure 45. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Type in 2019
Figure 46. APAC Equine Pharmaceuticals and Supplements Consumption Market Share by Application in 2019
Figure 47. China Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 48. China Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 55. India Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 56. India Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Countries in 2019
Figure 60. Europe Equine Pharmaceuticals and Supplements Value Market Share by Countries in 2019
Figure 61. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Type in 2019
Figure 62. Europe Equine Pharmaceuticals and Supplements Consumption Market Share by Application in 2019
Figure 63. Germany Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 65. France Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 66. France Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 67. UK Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 68. UK Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Equine Pharmaceuticals and Supplements Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Market Share by Application in 2019
Figure 77. Egypt Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Equine Pharmaceuticals and Supplements Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Equine Pharmaceuticals and Supplements Value Growth 2015-2020 ($ Millions)
Figure 87. Global Equine Pharmaceuticals and Supplements Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Equine Pharmaceuticals and Supplements Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 90. Americas Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 91. APAC Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 92. APAC Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 93. Europe Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 94. Europe Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 97. United States Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 98. United States Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 99. Canada Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 100. Canada Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 101. Mexico Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 102. Mexico Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 103. Brazil Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 104. Brazil Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 105. China Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 106. China Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 107. Japan Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 108. Japan Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 109. Korea Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 110. Korea Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 113. India Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 114. India Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 115. Australia Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 116. Australia Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 117. Germany Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 118. Germany Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 119. France Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 120. France Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 121. UK Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 122. UK Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 123. Italy Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 124. Italy Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 125. Russia Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 126. Russia Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 127. Spain Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 128. Spain Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 129. Egypt Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 130. Egypt Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 131. South Africa Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 132. South Africa Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 133. Israel Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 134. Israel Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 135. Turkey Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 136. Turkey Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Equine Pharmaceuticals and Supplements Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Equine Pharmaceuticals and Supplements Value 2021-2025 ($ Millions)
Figure 139. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 140. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 141. Merck Animal Health Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 142. Bayer Animal Health Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 143. Elanco Animal Health Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 144. Zoetis Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 145. Virbac Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 146. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 147. Norbrook Equine Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 148. CEVA Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 149. Vetoquinol Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 150. Ouro Fino Saude Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 151. Audevard Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Figure 152. Protexin Healthcare Equine Pharmaceuticals and Supplements Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets